Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial. Submitted by rgarcia on Mon, 03/23/2020 - 14:52 Martin-Broto J, Cruz J, Penel N, et al. Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial. Lancet Oncol. 2020;21(3):456-466. doi:10.1016/S1470-2045(19)30826-5.
